Skip to main content
OpenTrials
Completed

NCT Number: NCT02099214

Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis

Hereditary haemochromatosis (HHC) is a frequent disease in Brittany (5 to 7‰), responsible first for biological disorder in blood iron parameters and minor clinical disorders, before evolving to potential life-threatening consequences such as diabetes, liver cirrhosis and congestive heart failure.

The improvement of screening and treatments made those severe affections rare enough not to evaluate myocardial iron overload a systematic part of the starting check-up. Nonetheless this myocardial iron overload might have severe implications on cardiac function on a long term basis.

A single trial was conducted on limited number of patients with 1.5 Tesla MRI, which showed a myocardial iron overload (defined by a myocardium T2* value <20ms) in 19% of the subjects.

The main objective of this study is to precisely estimate cardiac iron overload in treatment naive patients with newly diagnosed HFE hereditary haemochromatosis with a 3 Tesla MRI, more sensitive than the 1.5 Tesla one, in order to later appreciate its correlation with cardiac morbidity in HHC.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rennes University Hospital

Rennes, 35000, France

About this study

Since the wide use of phlebotomy was implemented the incidence of congestive heart failure in HHC became quite low. As such, the interest towards the initial diagnosis and cardiological follow-up has been lesser. A subclinical myocardial iron overload can nevertheless exist and eventually lead to functional consequences in the medium and long term if neglected, even evolve into heart failure and preserved ejection fraction.

The expected aftermath of this study is :

  • The estimation of the frequency of myocardial iron overload measured by 3 Tesla MRI in patient with HFE hereditary haemochromatosis;
  • The assessment of its consequences on heart function;
  • The appreciation of a cardiological assessment strategy in patients with HFE hereditary haemochromatosis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients :

  • Adults older than 18 ;
  • Newly diagnosed with HFE hereditary haemochromatosis by genetic testing (homozygous for the C283Y mutation on HFE gene);
  • Treatment-naive;
  • Showing a ferritin level higher than 200µg/l for women and higher than 300µg/L for men;
  • Affiliated to French Social Security;
  • Having given a written informed consent.

Healthy volunteers:

  • Adults older than 18;
  • Presenting all the following criterions:
  • Normal cardiovascular physical examination: no signs of cardiac insufficiency, no pathological cardiac murmur, normal EKG (regular sinus rhythm, no high degree AV nor ventricular blocks, no rhythm anomaly),
  • Body Mass Index <27 kg/m²,
  • Normal routine blood biology (blood count, MCV, serum iron, ferritin, transferrin saturation);
  • Affiliated to French Social Security;
  • Having given a written informed consent.

Exclusion criteria

Patients :

MRI-related criterions :

  • Cardiac pacemaker or implanted defibrillator ;
  • Non MRI-compatible prosthetic cardiac valve;
  • Non MRI-compatible clips/stents/coils/etc.;
  • Cochlear implant;
  • Peripheral or neuronal stimulator;
  • Intra-ocular or brain metallic foreign bodies , foreign body in the eyes' vicinity, shrapnel or firearm wound;
  • Less than 4 weeks-old stents, less than 6 weeks-old osteosynthesis materials;
  • Claustrophobia;
  • Pumps, tattoos, permanent makeup, intrauterine device, patches;
  • Non-removable metallic or magnetic material in the vicinity of the analysed field.

Other criterions :

  • Haemodynamic instability / Acute respiratory insufficiency / Altered general status / Need for continuous monitoring incompatible wih MRI confines;
  • Pregnancy, breast feeding;
  • History of blood transfusion or iron supplementation;
  • Blood donation in the last 3 months;
  • Infection in the 7 days prior to the first visit;
  • Stay in altitude (>1500m) in the past 2 months;
  • Adults under legal protective regimen or deprived of liberty.

Healthy volunteers

  • Alcohol abuse (>20g per day for women, >30g per day for men);
  • Active tobacco intoxication or smoking cessation in the 6 last months;
  • Personal cardiovascular medical history;
  • Cardiovascular functional signs.

Treatment and study plan

3Tesla cardiac MRI

Device

Electrocardiogram (EKG)

Device

Iron and cardiac markers

Biological

Serum iron, serum transferrin, transferrin saturation, serum ferritin, NT-proBNP

Pregnancy test

Biological

Beta-hCG

Echocardiography at rest

Device

Transthoracic echocardiograph

Urinary pregnancy test

Biological

3Tesla abdominal MRI

Device

Primary outcomes

  1. Myocardial T2* values in haemochromatosis compared to healthy volunteers

    Time frame: Day 1

    Assessment of the percentage rate of patients presenting a lower T2* value than the baseline defined by the mean of T2* values measured in healthy volunteers with a 1 standard deviation margin.

Secondary outcomes

  1. Mean T2 values in healthy volunteers and patients with HFE-related haemochromatosis

    Time frame: Day 1

    Comparison of the mean T2 values in healthy volunteers and patients with HFE-related haemochromatosis

  2. Echocardiographic parameters of systolic and diastolic functions and myocardial deformation

    Time frame: Day 1

  3. Myocardial T2 and T2* values in both groups

    Time frame: Day 1

  4. Liver T2/T2* values

    Time frame: Day 1

    Correlation between liver T2/T2* and myocardial T2/T2*

  5. Pancreas T2/T2* values

    Time frame: Day 1

    Correlation between pancreas T2/T2* and myocardial T2/T2*

  6. Spleen T2/T2* values

    Time frame: Day 1

    Correlation between spleen T2/T2* and myocardial T2/T2*

Sponsors and collaborators

Lead sponsor

Rennes University Hospital

Other

Registry information

Official study title

Estimation of Myocardial Iron Overload by 3 Tesla MRI and Cardiac Functional Consequences in Patients With HFE Hereditary Haemochromatosis. Pilot Study

Acronym: HEMOCOEUR

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Mar 28, 2014
Registry last updated
Oct 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.